Daniel Johnson has extensive experience in the pharmaceutical industry, beginning with a role as a Territory Representative at Merrill Dow Pharmaceuticals from 1985 to 1988. At GSK, from 1988 to May 2018, Daniel served in various positions, notable for increasing the Breo market share in the Tampa Bay area from 3% in 2015 to 30.5% in 2017 as a Respiratory Specialist. Currently, Daniel holds two positions at Pfizer, working as a Senior Healthcare Representative for the Biosimilar Portfolio and as a Field Reimbursement Manager for Rare Disease since July 2018. Daniel earned a Bachelor of Arts degree in Physics from the University of South Florida.
This person is not in any teams
This person is not in any offices